Ye Yun, Li Su-Liang, Wang Jian-Jun
Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Emergency Department, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Front Oncol. 2020 Dec 1;10:578948. doi: 10.3389/fonc.2020.578948. eCollection 2020.
Previous studies have shown that miR-100-5p expression is abnormal in prostate cancer. However, the role and regulatory mechanism of miR-100-5p requires further investigation. Thus, the aim of this study was to observe the effects of miR-100-5p on the proliferation, migration and invasion of prostate cancer (PCa) cells and to explore the potential related regulatory mechanism.
Differential miRNA expression analysis was performed using next-generation sequencing (NGS) in the patients with PCa and benign prostatic hyperplasia (BPH). The expression levels of miR-100-5p were detected using real-time fluorescence quantitative PCR (qRT-PCR). PCa cells were transfected with NC-mimics or miR-100-5p mimics, inhibitor by using liposome transfection. Moreover, the CCK-8 proliferation assay, colony formation assay, cell scratch assay and Transwell assay were used to detect the effects of miR-100-5p on cell proliferation, migration, and invasion. In addition, the target gene of miR-100-5p was verified by luciferase reporter gene assay, and the influence of miR-100-5p on the expression of mTOR mRNA by qRT-PCR and the expression of mammalian target of rapamycin (mTOR) protein was detected by western blot and immunohistochemical staining.
Differential expression analysis of high-throughput sequencing data showed low expression of miR-100-5p in the patients of PCa. It was further confirmed by qRT-PCR that the expression of miR-100-5p in PCa cells was significantly lower than that in RWPE-1 cells (<0.01). miR-100-5p expression in lymph node carcinoma of prostate(LNCaP) cells was markedly upregulated after transfection with miR-100-5p mimics (<0.01), while cell proliferation, migration and invasion capacities were clearly reduced (<0.01). mTOR mRNA and protein expression was also substantially lowered (<0.01) and mTOR adjusted the expression of NOX4. Finally, we further confirmed by immunohistochemical staining that miR-100-5p regulated the expression of mTOR and NOX4.
miR-100-5p is expressed at low levels in PCa cells, and it can suppress PCa cell proliferation, migration and invasion, the mechanism of which is related to downregulating the expression of mTOR.
既往研究表明,miR-100-5p在前列腺癌中表达异常。然而,miR-100-5p的作用及调控机制尚需进一步研究。因此,本研究旨在观察miR-100-5p对前列腺癌细胞增殖、迁移和侵袭的影响,并探讨其潜在的相关调控机制。
采用下一代测序(NGS)技术对前列腺癌患者和良性前列腺增生(BPH)患者进行差异miRNA表达分析。采用实时荧光定量PCR(qRT-PCR)检测miR-100-5p的表达水平。利用脂质体转染法将NC-mimics或miR-100-5p mimics、抑制剂转染至前列腺癌细胞。此外,采用CCK-8增殖试验、集落形成试验、细胞划痕试验和Transwell试验检测miR-100-5p对细胞增殖、迁移和侵袭的影响。另外,通过荧光素酶报告基因试验验证miR-100-5p的靶基因,采用qRT-PCR检测miR-100-5p对mTOR mRNA表达的影响,通过蛋白质印迹法和免疫组织化学染色检测雷帕霉素哺乳动物靶蛋白(mTOR)蛋白的表达。
高通量测序数据的差异表达分析显示,前列腺癌患者中miR-100-5p表达较低。qRT-PCR进一步证实,前列腺癌细胞中miR-100-5p的表达明显低于RWPE-1细胞(<0.01)。用miR-100-5p mimics转染前列腺癌细胞系(LNCaP)后,miR-100-5p表达显著上调(<0.01),而细胞增殖、迁移和侵袭能力明显降低(<0.01)。mTOR mRNA和蛋白表达也显著降低(<0.01),且mTOR调节NOX4的表达。最后,通过免疫组织化学染色进一步证实miR-100-5p调节mTOR和NOX4的表达。
miR-100-5p在前列腺癌细胞中低表达,可抑制前列腺癌细胞的增殖、迁移和侵袭,其机制与下调mTOR表达有关。